Fundraising FoxSTATION F — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Phagos develops phage therapy treatments as an alternative to antibiotics, using its Alphagos platform that combines microbiology and AI to design targeted bacterial medicines against antimicrobial resistance.
AgTechAI & Machine LearningBiotechIvry-Sur-Seine, FR
Alexandros Pantalis(Executive Officer, Director)inAdèle James(CTO)in
BoardRobert Kniaz(Director)inXin Ma(Director)Geoffroy Dubus(Director)in
Co-investorsAcurio VenturesBeyond CapitalCapagroEntrepreneur FirstHoxton VenturesAgFunder+3 more
Spore.Bio develops real-time microbial detection technology for industrial quality control, replacing traditional Petri dish culture methods used in factory settings.
AI & Machine LearningBiotechDeep TechFoodTechParis, FR
Amine Raji(CEO)inMaxime Mistretta(CTO)inMohamed Tazi(COO)inMichael J. Miller(VP of Scientific and Regulatory Affairs)in
Co-investorsBetter AngleEntrepreneur FirstKima VenturesLocalGlobeNO LABEL VENTURESPhoenix Court+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.